ABRAMS.wiki는 다음과 관련된 실제 배송, 위치, 경쟁업체, 구매자, 고객, 공급업체, 공급망, 제품, 제품 포트폴리오, 연락처, 직원, 매출 정보를 제공합니다:

ABRAMS world trade wiki는 UN Comtrade (유엔 데이터베이스)와 OECD (경제협력개발기구)의 파트너로서, 지능형 알고리즘과 인공지능(AI)을 활용하여 수십억 개의 통계 데이터뿐만 아니라 화물 및 관세 데이터를 분석하고 이를 바탕으로 "독특한 비즈니스 인텔리전스 포털"을 개발했습니다 (인용: UN Comtrade / 참조).

이 페이지에서는 저희 연구팀이 개별적으로 준비한 Glenmark Pharmaceuticals Inc. USA의 시장 활동에 대한 통찰을 얻을 수 있습니다.

경쟁업체, 공급업체 또는 고객의 최신 배송 내역을 무료로 확인해 보세요!

주요 경쟁업체의 최신 배송을 분석하여 공급업체, 고객 및 제품에 대한 정보를 얻으세요, 또는 다른 회사 를 선택하세요.

다단계 공급망 투명성

ABRAMS world trade wiki 는 1차 공급업체(Tier-1)의 직접적인 공급업체와 구매자만을 보여주는 것이 아닙니다. 저희 도구인 Supply Chain Intelligence 는 Tier-1 이상의 가시성 장벽을 허물어, 전체 공급망 네트워크 에 대한 포괄적인 통찰을 제공하며, 다단계 투명성 을 단 한 번의 클릭으로 제공합니다.

Supply Chain Intelligence - Export and Import

Glenmark Pharmaceuticals Inc. USA의 구매 부서의 담당자는 누구인가요?

ABRAMS world trade wiki는 Glenmark Pharmaceuticals Inc. USA의 구매 부서에서 현재 담당자를 찾을 수 있는 무료 서비스를 제공합니다.

무료로 받으세요:

연락 담당자는 누구인가요판매부서Glenmark Pharmaceuticals Inc. USA

ABRAMS world trade wiki는 Glenmark Pharmaceuticals Inc. USA의 영업 부서에서 현재 담당자를 찾을 수 있는 무료 서비스를 제공합니다.

무료로 받으세요:

다음에 대한 정보는 어디에서 찾을 수 있나요규정 준수에 Glenmark Pharmaceuticals Inc. USA ?

ABRAMS world trade wiki는 전 세계에서 Glenmark Pharmaceuticals Inc. USA에 대한 최신 컴플라이언스 뉴스를 검색할 수 있는 무료 서비스를 제공합니다.

무료로 받으세요:

Glenmark Pharmaceuticals Inc. USA에 대한 최신 보도자료는 무엇인가요?

ABRAMS world trade wiki는 전 세계에서 Glenmark Pharmaceuticals Inc. USA에 대한 최신 보도자료를 검색할 수 있는 무료 서비스를 제공합니다.

무료로 받으세요:

Glenmark Pharmaceuticals Inc. USA의 공급업체는 누구인가요?: 회사의 성과는 공급업체에 크게 의존합니다. 따라서 신뢰할 수 있는 파트너 네트워크(공급업체, 딜러 및 제조업체)는 기본 요소입니다. 선하증권에서 __Glenmark Pharmaceuticals Inc. USA__의 40개의 국제 공급업체 가 확인되었으며, 이들이 회사가 의존하고 있는 업체들입니다. 예를 들어, Glenmark Pharmaceuticals Ltd. 회사는 123 건의 상품 배송 을 수행했습니다.

3 내에서 발견된 공급업체 국가 중 제품 구매의 주요 공급처는 인도 입니다. 해당 지역에서 5,490 개의 상품 발송이 확인되었습니다.

Glenmark Pharmaceuticals Inc. USA의 국제 조달 과 40개의 공급업체 에 대한 개요를 Company Transparency를 통해 확인하세요.
Glenmark Pharmaceuticals Inc. USA의 공급망은 어떻게 구성되어 있나요?: 일반적으로 Glenmark Pharmaceuticals Inc. USA 의 공급망 또는 공급 네트워크는 두 가지 관점에서 구분할 수 있습니다:

공급자 측면 (Tier-1 공급자는 직접 공급자, Tier-2는 Tier-1 공급자의 공급자, Tier-n은 Glenmark Pharmaceuticals Inc. USA 공급 네트워크의 모든 레벨에서 공급자입니다).

구매자 측면 (Tier-1 구매자는 직접 구매자, Tier-2는 Tier-1 구매자의 구매자, Tier-n은 Glenmark Pharmaceuticals Inc. USA 유통 네트워크의 모든 레벨에서 구매자입니다).

비즈니스의 안정성과 연속성을 보장하기 위해 공급망이나 공급 네트워크는 외부 영향이 Glenmark Pharmaceuticals Inc. USA 에 가할 수 있는 피해를 최소화하도록 구성되어야 합니다. 이것은 조달 분야(공급자의 손실은 대체 공급자가 보완해야 함)와 판매 분야(구매자의 손실은 대체 구매자가 보완해야 함) 모두에 적용됩니다.

일반적으로 리스크는 상품의 비가용성, 생산의 축소 또는 중단, 비즈니스 파트너의 손실 가능성, 또는 준수 규칙 위반(예: 환경 보호, 노동법)으로 인해 공급 네트워크에서 제외되는 것으로 간주될 수 있습니다.

이 리스크는 반드시 직접적인 비즈니스 파트너(Tier 1)에만 국한되지 않으며, 충분한 대체 공급자와 구매자가 마련되지 않은 경우 전체 공급망에 영향을 미칠 수 있습니다.

Get an overview of the international supply chain of Glenmark Pharmaceuticals Inc. USA (upstream/procurement and downstream/sales) from Tier-1 to Tier-n

E.G.: Tier 1 supplier Glenmark Pharmaceuticals Ltd.

ABRAMS world trade wiki는 첫 번째 계층(Tier-1)의 직접 공급자와 고객뿐만 아니라, Supply Chain Intelligence 도구에서 한 번의 클릭으로 여러 계층(Tier-n)에 걸친 공급 네트워크에 대한 포괄적인 인사이트를 제공합니다.
Is the supply chain of Glenmark Pharmaceuticals Inc. USA stable?: Each tier in the supply chain or supply network on the supplier side of Glenmark Pharmaceuticals Inc. USA involves a single risk. The more tiers, the more difficult it is to analyze and monitor the business partners. Suppliers of suppliers are generally unknown, so there is already an increasing risk at the second (Tier 2) level.

If e.g. a first Tier supplier is not adding any value, the supply chain can be shortened and the risk of failure can be minimized by skipping this supplier. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:

Analyze the potential of shortening and therefore stabilizing the supply chain of Glenmark Pharmaceuticals Inc. USA
Which products does Glenmark Pharmaceuticals Inc. USA purchase?: 국제 선하증권(Bill of Lading / Bills of Lading / BOL) 분석을 통해 __31 개의 다양한 제품 카테고리__가 확인되었으며, 이는 Glenmark Pharmaceuticals Inc. USA 이 구매한 것입니다.

이들은 HS 코드(HTS 코드 또는 관세율표 번호)를 통해 구분할 수 있습니다.

예를 들어, HS-Code 300490 는 다음과 같은 제품을 분류합니다:

„Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins or derivatives thereof used as vitamins)". 이 HS 코드는 총 3,480 번 확인되었습니다.

분석된 선하증권(Bill of Lading / Bills of Lading / BOL)의 제품 설명 에서 다음과 같은 다양한 공급업체로부터 구매한 제품 의 예시를 확인할 수 있습니다:

PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTI CEMIAINTRA ABDOMINAL INFECTIONS LOWER RESPIRA TORY INFECTIONS GYNECOLOGICAL INFECTIONS BONE AND JOINT INFECTIONS AND SKIN AND SKIN STRUC TURE INFECTIONS NAPROXEN SOD TAB MG N DC CODE FDA PRODUCT CODE NO. G C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USEANTI INFLAMMATORY ANALGESIC CARVEDILOL TAB . MG NDC CODE FDA PRODUCT CODE NO O C A HTS NO. . . ANDA NO. THERAPEUTICE USEBETA A DRENOACEPTOR ANTAGONIST CARVEDILOL TAB . M G NDC CODE FDA PRODUCT CODE NO O C A HTS NO. . . ANDA NO. THERAPEUTICE USEBETA ADRENOACEPTOR ANTAGONI ST GABAPENTIN TAB MG NDC CODE FDA PRODUCT CODENO N C A HTS NO. . . ANDA NO. THERAPEUTICE USEANTI CONVULSANT GABAPENTIN TAB MG NDC CODE FDA PRODUCT CODENO N C A H TS NO. . . ANDA NO. THERAPEUTICE USEANTICONVULSANT COMMERCIAL CUSTOM INVOIC E NO. F DT. . . F DT. . . F DT. . . F DT. . . F DT. . . GROSS WT. . KGS NET WT. . KGS DATA LOGGERS HUMIDITY SET TE MPERATURE DEGREES TEMPERATURE RANGE D EGREES TO DEGREES NOTIFY PARTY GLENMARK PHARMACEUTICALS INC RIVER DRIVE SUITE A NEW JERSEY ELMWOOD PARK USA NOTIFY PARTY GLENMARK PHARMACEUTICALS INC.USA C ORPORATE DRIVE NEW JERSEY MAHWAH USA LA BELER CODE

PHARMACEUTICAL COMMODITY

PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER CARVEDILOL TAB . MG NDC CODE FDA PRODUCT CODE NO O C A HTS NO. . . ANDA NO. THER APEUTICE USEBETA ADRENOACEPTOR ANTAGONIST CL INDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO . . . ANDA NO. THERAPEUTICE US E TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL I NFECTIONS LOWER RESPIRATORY INFECTIONS GYNECO LOGICAL INFECTIONS BONE AND JOINT INFECTIONS AND SKIN AND SKIN STRUCTURE INFECTIONS CLIND AMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEUTICE USE T REATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFE CTIONS LOWER RESPIRATORY INFECTIONS GYNECOLO GICAL INFECTIONS BONE AND JOINT INFECTIONS AN D SKIN AND SKIN STRUCTURE INFECTIONS FENOFIB RATE CAP MG NDC CODE FDA PRO DUCT CODE NO. JCE H. T. S NO. . . . ANDA NO. THERAPEUTICE USE INDICA TED AS ADJUNCTIVE THERAPY TO DIET FOR THE RED UCTION OF LDLC TOTALC TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTERO LEMIA OR MIXED DYSLIPIDEMIA COMMERCIAL CUST OM INVOICE NO. F DT. . . F DT. . . SBILL NO DT SEP SBILL NO DT SEP DATA L OGGERS HUMIDITY SET TEMPERATURE DEGREES TEMPERATURE RANGE DEGREES TO DEGREES N OTIFY PARTY GLENMARK PHARMACEUTICALS INC RIVER DRIVE SUITE A NEW JERSEY ELMWOOD PA RK USA

PART OF FCL PACKAGES CARTONS PHARMACE UTICALS AS UNDER ROSUVASTATIN TAB MG ND C CODE FDA PRODUCT CODE NO. J C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USE TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS AND TO PREVENT CARDIO VASCULAR DISEASE NITROGLYCERIN SUBLING TAB . MG NDC CODE FDA PRODUCT CODE NO. S C A H. T. S NO. . . AND A NO. THERAPEUTIC USE MEDICATION USED F OR HEART FAILUREHIGH BLOOD PRESSUREAND TO TRE AT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART NITROGLYCERIN SUBLING T AB . MG X NDC CODE FDA PRODUCT CODE NO. S C A H. T. S NO. . . ANDA NO. THERAPEUTIC USE MEDICATION U SED FOR HEART FAILUREHIGH BLOOD PRESSUREAND T O TREAT AND PREVENT CHEST PAIN FROM NOT ENOUG H BLOOD FLOW TO THE HEART NITROGLYCERIN SUBL ING TAB . MG X NDC CODE FDA PR ODUCT CODE NO. S C A H. T. S NO. . . ANDA NO. THERAPEUTIC USE MEDICAT ION USED FOR HEART FAILUREHIGH BLOOD PRESSURE AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING TAB . MG NDC CODE FD A PRODUCT CODE NO. S C A H. T. S NO. . . ANDA NO. THERAPEUTIC USE MED ICATION USED FOR HEART FAILUREHIGH BLOOD PRES SUREAND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART SOLIFENAC IN SUCCINATE TAB MG NDC CODE F DA PRODUCT CODE NO. KCA H. T. S NO. ANDA NO. INDICATED FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE URGENCY AND URI NARY FREQUENCY COMMERCIAL CUSTOM INVOICE NO . F DT. . . F DT . . . F DT. . . F DT. . . F DT. . . SBILL NO DT SEP SBILL NO DT SEP SBILL NO DT SEP SB ILL NO DT SEP SBILL NO DT SEP GROSS WT. . KGS NET WT. . KGS DATA LOGGERS HUMIDITY SET TEMPERA TURE DEGREES TEMPERATURE RANGE DEGREE S TO DEGREES NOTIFY PARTY GLENMARK SPECIA LTY S.A. SWITZERLAND (GSSA) PLACE DU PORT N EUCHATEL SWITZERLAND

PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER SIROLIMUS TAB MG NDC CODE FDA PRODUCT CODE NO. T C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USE TO PREVENT REJECTION OF KID NEY TRANSPLANTS. TACROLIMUS OINTMENT . GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSI VE AGENT PIMECROLIMUS CREAM GM NDC CODE FDA PRODUCT CODE NO. S C J H . T. S NO. . . . ANDA NO. THER APEUTICE USE AS SECOUNDLINE THERAPY FOR THE SHORTTERM AND NONCONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONI MMUNOCOMPROMISED ADULT AND CHILDREN YEARS O F AGE TACROLIMUS CAP MG NDC CODE HTS NO . . . FDA CODE T C E ANDA NO. THERAPEUTIC USE TO PREVENT REJECTION OF A KIDNEYHEART OR LIVER TRANSPLA NT TACROLIMUS OINTMENT . GM NDC CODE FDA PRODUCT CODE NO. T C J H. T . S NO. . . ANDA NO. THERAPEUT ICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT TACR OLIMUS CAP MG NDC CODE HTS NO . . . FDA CODE T C E ANDA NO. THERAPEUTIC USE TO PREVENT REJECTION OF A KIDNEYHEART OR LIVER TRANSPLANT TACROLI MUS OINTMENT . GM NDC CODE FD A PRODUCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE TOP ICAL IMMUNOSUPPRESSIVE AGENT GABAPENTIN TAB MG NDC CODE FDA PRODUCT COD ENO N C A HTS NO. . . ANDA NO. THERAPEUTICE USEANTICONVULSANT GABAPEN TIN TAB MG NDC CODE FDA PRO DUCT CODENO N C A HTS NO. . . ANDA NO. THERAPEUTICE USEANTICONVULSANT COMMERCIAL CUSTOM INVOICE NO. F DT. . . F DT. . . F DT. . . F DT. . . F DT. . . F DT. . . SBILL NO DT SEP SBILL NO DT SEP SBILL NO DT SEP SBILL NO DT SEP SBILL NO DT SEP SBILL NO DT SEP GRO SS WT. . KGS NET WT. . KGS D ATA LOGGERS HUMIDITY SET TEMPERATURE DE GREES TEMPERATURE RANGE DEGREES TO DEG REES NOTIFY PARTY GLENMARK PHARMACEUTICALS INC RIVER DRIVE SUITE A NEW JERSEY ELM WOOD PARK USA NOTIFY PARTY GLENMARK PHARMACEUTICALS INC.USA CORPORATE DRIVE N EW JERSEY MAHWAH USA LABELER CODE

PACKAGES CARTONS PHARMACEUTICALS AS U NDER CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEU TICE USE TREATMENT OF NUMEROUS INFECTIONS INC LUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDO MINAL INFECTIONS LOWER RESPIRATORY INFECTIONS GYNECOLOGICAL INFECTIONS BONE AND JOINT INFE CTIONS AND SKIN AND SKIN STRUCTURE INFECTIONS CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEUTIC E USE TREATMENT OF NUMEROUS INFECTIONS INCLUD ING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMIN AL INFECTIONS LOWER RESPIRATORY INFECTIONS GY NECOLOGICAL INFECTIONS BONE AND JOINT INFECTI ONS AND SKIN AND SKIN STRUCTURE INFECTIONS C LINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S N O. . . ANDA NO. THERAPEUTICE U SE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFECTIONS LOWER RESPIRATORY INFECTIONS GYNEC OLOGICAL INFECTIONS BONE AND JOINT INFECTIONS AND SKIN AND SKIN STRUCTURE INFECTIONS SIRO LIMUS TAB . MG NDC CODE FDA P RODUCT CODE NO. T C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USE TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. TAC ROLIMUS OINTMENT . GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT TACROLIMUS OINTMENT . GM NDC CODE FDA P RODUCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE TOPICA L IMMUNOSUPPRESSIVE AGENT CETIRIZINE HCL TAB MG (FT) NDC CODE FDA PRODUCT CODE X A A H. T. S NO. . . AN DA NO. THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCL TAB MG (FT) NDC CODE FDA PRODUCT CODE X A A H. T. S NO. . . ANDA NO. THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCL TAB MG (FT) NDC CODE FDA PRODUCT CODE X A A H. T. S NO. . . ANDA NO. THERAPEUTICE USE ANTIHISTAMINE CETIRI ZINE HCL TAB MG NDC CODE FDA PRODUCT CODE. X C A HTS NO. . . ANDA NO. THERAPEUTICE USE. ANTIHISTAM INE COMMERCIAL CUSTOM INVOICE NO. F DT. . . F DT. . . F DT. . . SBILL NO DT AUG SBILL NO DT AUG SBILL NO DT AUG GROSS WT. . KGS NET WT. . KGS DATA LOGGERS HUMIDITY SET TEMPERATURE DEGREES TEMPERATURE RAN GE DEGREES TO DEGREES NOTIFY PARTY GL ENMARK PHARMACEUTICALS INC CORPORATE DRIV E NEW JERSEY MAHWAH USA

PACKAGES CARTONS PHARMACEUTICALS AS UNDER CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . ANDA NO. THERAPEU TICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDO MINAL INFECTIONS LOWER RESPIRATORY INFECTIONS GYNECOLOGICAL INFECTIONS BONE AND JOINT INFECTIONS AND SKIN AND SKIN STRUCTURE INFECTIONS CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . ANDA NO. THERAPEUTIC E USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMIN AL INFECTIONS LOWER RESPIRATORY INFECTIONS GYNECOLOGICAL INFECTIONS BONE AND JOINT INFECTIONS AND SKIN AND SKIN STRUCTURE INFECTIONS C LINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFECTIONS LOWER RESPIRATORY INFECTIONS GYNECOLOGICAL INFECTIONS BONE AND JOINT INFECTIONS AND SKIN AND SKIN STRUCTURE INFECTIONS SIRO LIMUS TAB MG NDC CODE FDA PRODUCT CODE NO. T C A H. T. S NO. . . ANDA NO. THERAPEUTICE USE TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. TAC ROLIMUS OINTMENT GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT TACROLIMUS OINTMENT GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT CETIRIZINE HCL TAB MG (FT) NDC CODE FDA PRODUCT CODE X A A H. T. S NO. . AN DA NO. THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCL TAB MG (FT) NDC CODE FDA PRODUCT CODE X A A H. T. S NO. . ANDA NO. THERAPEUTICE USE ANTIHISTAMINE CETIRIZINE HCL TAB MG (FT) NDC CODE FDA PRODUCT CODEX A A H. T. S NO. . ANDA NO. THERAPEUTICE USE ANTIHISTAMINE CETIRI ZINE HCL TAB MG NDC CODE FDA PRODUCT CODE. X C A HTS NO. . ANDA NO. THERAPEUTICE USE. ANTIHISTAMINE COMMERCIAL CUSTOM INVOICE NO. F DT. . F DT. . F DT. . SBILL NO DT AUG SBILL NO DT AUG SBILL NO DT AUG GROSS WT. KGS NET WT. KGS DATA LOGGERS HUMIDITY SET TEMPERATURE DEGREES TEMPERATURE RANGE DEGREES TO DEGREES NOTIFY PARTY GL ENMARK PHARMACEUTICALS INC CORPORATE DRIVE NEW JERSEY MAHWAH USA

PACKAGES CARTONS PHARMACEUTICALS AS UNDER TOPIRAMATE ER CAP (Q) MG NDC CODE . M C B CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFECTIONS LOWER RESPIRATORY INFECTIONS GYNECOLOGICAL INFECTIONS BONE AND JOINT INFECTIONS AND SKIN AND SKIN STRUCTURE INFECTIONS CLI NDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFECTIONS LOWER RESPIRATORY INFECTIONS GYNECOLOGICAL INFECTIONS BONE AND JOINT INFECTIONS AND SKIN AND SKIN STRUCTURE INFECTIONS TACROL IMUS OINTMENT GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT TACROLIMUS OINTMENT GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT TACROLIMUS OINTMENT . GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT BISOPROLOLHCTZ TAB MG NDC CODE FDA PRODUCT CODE NO O D A HTS NO. . ANDA NO. THERAPEUTICE USEBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION TOPIRAMATE ER CAP (Q) MG NDC CODE . M C B CARVEDILOL TAB MG NDC CODE FDA PRODUCT CODE NO O C A HTS NO. . ANDA NO. THER APEUTICE USEBETA ADRENOACEPTOR ANTAGONIST GA BAPENTIN TAB MG NDC CODE FD A PRODUCT CODENO N C A HTS NO. . ANDA NO. THERAPEUTICE USEANTICONVUL SANT ROSUVASTATIN TAB MG NDC CODE FDA PRODUCT CODE NO. J C A H. T. S NO. . ANDA NO. THERAPEUTI CE USE TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS AND TO PREVENT CARDIOVASCULAR DISEASE TERIFLUNOMIDE TAB MG NDC CODE FDA PRODUCT CODE NO. L C A H. T. S NO. . ANDA NO. THERAPEUTI CE USE MULTIPLE SCLEROSIS AGENT COMMERCIAL CUSTOM INVOICE NO. F DT. . F DT. . F DT . . F DT. . F DT. . F DT. F DT. . F DT. . F DT. . SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL SBIL L NO DT JUL SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL GROSS WT. KGS NET WT. . KGS DATA LOGGERS HUMIDITY SET TEMPERATURE DEGREES TEMPERATURE RANGE DEGREES TO DEGREES NOTIFY PARTY GLENMARK PHA RMACEUTICALS INC CORPORATE DRIVE NEW JERSEY MAHWAH USA NOTIFY PARTY GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT NEUCHATEL SWITZERLAND

PACKAGES CARTONS PHARMACEUTICALS AS U NDER TOPIRAMATE ER CAP (Q) MG NDC CODE . . . M C B CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDIN G BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFECTIONS LOWER RESPIRATORY INFECTIONS GYNE COLOGICAL INFECTIONS BONE AND JOINT INFECTION S AND SKIN AND SKIN STRUCTURE INFECTIONS CLI NDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING B UT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL IN FECTIONS LOWER RESPIRATORY INFECTIONS GYNECOL OGICAL INFECTIONS BONE AND JOINT INFECTIONS A ND SKIN AND SKIN STRUCTURE INFECTIONS TACROL IMUS OINTMENT . GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE T OPICAL IMMUNOSUPPRESSIVE AGENT TACROLIMUS OI NTMENT . GM NDC CODE FDA PROD UCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE TOPICAL I MMUNOSUPPRESSIVE AGENT TACROLIMUS OINTMENT . GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUP PRESSIVE AGENT BISOPROLOLHCTZ TAB . MG NDC CODE FDA PRODUCT CODE NO O D A HTS NO. . . ANDA NO. THERAPEUTICE USEBISOPROLOL FUMARATE AND HYDRO CHLOROTHIAZIDE TABLETS ARE INDICATED IN THE M ANAGEMENT OF HYPERTENSION TOPIRAMATE ER CAP (Q) MG NDC CODE . . . M C B CARVEDILOL TAB MG NDC CODE FDA PRODUCT CODE NO O C A HTS NO. . . ANDA NO. THER APEUTICE USEBETA ADRENOACEPTOR ANTAGONIST GA BAPENTIN TAB MG NDC CODE FD A PRODUCT CODENO N C A HTS NO. . . ANDA NO. THERAPEUTICE USEANTICONVUL SANT ROSUVASTATIN TAB MG NDC CODE FDA PRODUCT CODE NO. J C A H. T. S NO. . . . ANDA NO. THERAPEUTI CE USE TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS AND TO PREVENT CARDIOVASCULAR DIS EASE TERIFLUNOMIDE TAB MG NDC CODE FDA PRODUCT CODE NO. L C A H. T. S NO. . . ANDA NO. THERAPEUTI CE USE MULTIPLE SCLEROSIS AGENT COMMERCIAL CUSTOM INVOICE NO. F DT. . . F DT. . . F DT . . . F DT. . . F DT. . . F DT. . . F DT. . . F DT. . . F DT. . . SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL SBIL L NO DT JUL SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL GROSS WT. . KGS NET WT. . KGS DATA LOGGERS HUMIDITY SET TEMP ERATURE DEGREES TEMPERATURE RANGE DEG REES TO DEGREES NOTIFY PARTY GLENMARK PHA RMACEUTICALS INC CORPORATE DRIVE NEW JERS EY MAHWAH USA NOTIFY PARTY GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PO RT NEUCHATEL SWITZERLAND

PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER METFORMIN HCL ER TAB (Z) MG NDC CODE FDA PRODUCT CODE NO. P C A H. T. S NO. . . . AN DA NO. THERAPEUTICE USE THE MANAGEMENT OF TYPE DIABETES BISOPROLOLHCTZ TAB . MG NDC CODE FDA PRODUCT CODE NO O D A HTS NO. . . ANDA NO. THERAPEUTICE USEBISOPROLOL FUMARATE AND HY DROCHLOROTHIAZIDE TABLETS ARE INDICATED IN TH E MANAGEMENT OF HYPERTENSION. CARVEDILOL TAB . MG NDC CODE FDA PRODUCT C ODE NO O C A HTS NO. . . ANDA N O. THERAPEUTICE USEBETA ADRENOACEPTOR AN TAGONIST CARVEDILOL TAB MG NDC CODE FDA PRODUCT CODE NO O C A HTS NO. . . ANDA NO. THERAPEUTICE US EBETA ADRENOACEPTOR ANTAGONIST TACROLIMUS OI NTMENT . GM NDC CODE FDA PROD UCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE TOPICAL I MMUNOSUPPRESSIVE AGENT TACROLIMUS OINTMENT . GM NDC CODE FDA PRODUCT CODE NO. T C J H. T. S NO. . . ANDA NO. THERAPEUTICE USE TOPICAL IMMUNOSUP PRESSIVE AGENT PIMECROLIMUS CREAM GM NDC CODE FDA PRODUCT CODE NO. S C J H. T. S NO. . . . ANDA NO. THERAPEUTICE USE AS SECOUNDLINE THERAPY FO R THE SHORTTERM AND NONCONTINUOS CHRONIC TRER TMENT OF MILD TO MODERATE ATOPIC DERMATITIS I N NONIMMUNOCOMPROMISED ADULT AND CHILDREN Y EARS OF AGE BISOPROLOLHCTZ TAB . MG NDC CODE FDA PRODUCT CODE NO O D A HTS NO. . . ANDA NO. THE RAPEUTICE USEBISOPROLOL FUMARATE AND HYDROCHL OROTHIAZIDE TABLETS ARE INDICATED IN THE MANA GEMENT OF HYPERTENSION. TACROLIMUS OINTMENT . GM NDC CODE FDA PRODUCT COD E NO. T C J H. T. S NO. . . AND A NO. THERAPEUTICE USE TOPICAL IMMUNOSU PPRESSIVE AGENT COMMERCIAL CUSTOM INVOICE N O. F DT. . . F D T. . . F DT. . . F DT. . . F DT. . . SBILL NO DT JUL SBILL NO DT JUL SBILL NO DT JUL S BILL NO DT JUL SBILL NO DT JUL GROSS WT. . KGS NET WT. . KGS DATA LOGGERS SET TEMPERATURE DEGREES NOTIFY PARTY GLENMARK PHARMACEUTIC ALS INC CORPORATE DRIVE NEW JERSEY MAHWAH USA

Get an overview of internationally purchased products by Glenmark Pharmaceuticals Inc. USA with Company Transparency
Is Glenmark Pharmaceuticals Inc. USA able to reduce costs in the upstream supply chain?: Each tier in the supply chain or supply network of Glenmark Pharmaceuticals Inc. USA is adding value and therefore costs. The more tiers, the more expensive the product gets. Supply chains are normally not very transparent, trade secrets are part of the survival tactics in each stage of the value chain, especially for trading companies.

If e.g. a Tier-1 supplier from Glenmark Pharmaceuticals Inc. USA that primarily trades a product and doesn’t add any value (only fulfills the distributor function) it is possible to shorten the supply chain and reduce purchasing costs. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:

Analyze the potential of shortening the supply chain of Glenmark Pharmaceuticals Inc. USA and saving costs on the procurement side.

Is Glenmark Pharmaceuticals Inc. USA a reliable supplier?: Each company contributes significantly minimizing risks for its buyers, through its own stability. Internal risks (endogenous factors) can be e.g. financially (financial ratios, free cash flow, balance sheets) or operationally (production, lead times). Since 2021, external risks have increased due to worldwide shortages and are an important factor as to whether a supplier such as Glenmark Pharmaceuticals Inc. USA can itself reliably deliver due to external dependencies (exogenous factors).

To assess this, data analysis should be conducted to get practical answers:

How is the supply chain or supply network structured on the supplier side of Glenmark Pharmaceuticals Inc. USA? Are there suppliers or products in the supply chain that are reported as critical, e.g. in international media?
Does Glenmark Pharmaceuticals Inc. USA have procurement problems at the moment?: The more constant incoming shipments, the better one can determine possible procurement problems of a company like Glenmark Pharmaceuticals Inc. USA

Since 2021, there are increasingly external factors due to global supply shortages, whether a company, no matter manufacturer or distributor, can reliably deliver through dependencies.

Based on the statistical trend of shipments (in terms of the number of shipments and respectively the quantity of goods) it is possible to analyze current procurement stability and thus ultimately also to derive an indication of the company’s delivery and performance capability.

Here you can see an analysis of shipments from international suppliers to Glenmark Pharmaceuticals Inc. USA in the last few months with Company Transparency

What is the CO₂ footprint and sustainability of Glenmark Pharmaceuticals Inc. USA products?: Sourcing products as regionally as possible with short shipping routes and the use of sustainable materials define the CO₂ footprint and sustainability of the products of any company, including Glenmark Pharmaceuticals Inc. USA

After many companies, predominantly due to cost savings, have been building their networks increasingly internationally for years, there is now an increasing trend of so-called “on-shoring” or “near-shoring”. Attempting to include suppliers who are the closest to the supply chain because of financial, risk, environmental and image aspects:

Saving international freight costs, which have risen extremely since 2021.

Minimizing risks caused by logistics problems (e.g. the Suez Canal obstruction in 2021)

Attempting to reduce the carbon footprint when purchasing products.

Setting and meeting sustainability goals for own products of Glenmark Pharmaceuticals Inc. USA

Based on the development of current shipments (in terms of number of shipments and quantity of goods) and changes in international suppliers and routes, it is possible to analyze the extent to which Glenmark Pharmaceuticals Inc. USA has already made efforts in recent months and years, to focus on environmentally relevant aspects, like carbon footprint and sustainability in its business activities.

Get an overview of the international shipments that have an impact on the CO₂ footprint, as well as the sustainability of Glenmark Pharmaceuticals Inc. USA

Who are the competitors of Glenmark Pharmaceuticals Inc. USA?: Generally you can differentiate the competition of Glenmark Pharmaceuticals Inc. USA by the purchase and sales perspective.

Start the competitive analysis on the purchase side.

Start the competitive analysis on the sales side.
Who are the competitors of Glenmark Pharmaceuticals Inc. USA on the purchase side?: Competitors of Glenmark Pharmaceuticals Inc. USA on the purchase side (procurement of raw materials and components for production or distribution) are exposed on ABRAMs wiki under Competitive Intelligence, purchased products, classified by HS-Codes (e.g. 300490, 300660) or by top product terms.
Who are the competitors of Glenmark Pharmaceuticals Inc. USA on the sales side (selling similar products)?: Competitors on the sales side of Glenmark Pharmaceuticals Inc. USA (selling raw materials or components for production or distribution) are exposed on ABRAMS wiki under Competitive Intelligence, sold products classified by HS-Codes or by top product terms.